A Study to Explore the Efficacy and Safety of HWH486 in Adults With Chronic Spontaneous Urticaria
Status:
RECRUITING
Trial end date:
2026-01-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-bind and placebo-controlled phase IIa dose-finding study to assess the safety and efficacy of HWH486 in adults with chronic spontaneous urticaria (CSU). In addition, the pharmacokinetic characteristics will also be investigated.
Phase:
PHASE2
Details
Lead Sponsor:
Hubei Biological Medicine Industrial Technology Institute Co., Ltd.